Table 1.
Patient's characteristics.
| Patient's characteristics | Vitamin D supplementation | P | |
|---|---|---|---|
| (+) (n=68) |
(-) (n=68) |
||
| Age (years) | 63.8±9.3 | 62.7±8.9 | 0.761 |
| Female gender (%) | 46.3 | 48.1 | 0.827 |
| Hypertension (%) | 62.5 | 63.7 | 0.834 |
| Diabetes mellitus (%) | 37.9 | 35.4 | 0.637 |
| Hyperlipidemia (%) | 32.8 | 34.7 | 0.682 |
| Smoking history (%) | 24.6 | 27.1 | 0.753 |
| COPD, n (%) | 28.7 | 26.9 | 0.756 |
| Duration of hospitalization (days) | 8.1±2.3 | 7.9±2.1 | 0.891 |
| Left ventricular ejection fraction (%) | 62.7±6.9 | 61.3±7.1 | 0.843 |
| Left atrial diameter (mm) | 38.9 | 39.3 | 0.837 |
| Cross-clamp time (min) | 74 (71.0-78.0) | 75 (72-80) | 0.672 |
| Cardiopulmonary bypass time (min) | 96 (84.0-101) | 94 (80.0-98.0) | 0.718 |
| Beta-blocker therapy (%) | 86 | 89 | 0.584 |
| Statin therapy (%) | 92 | 94 | 0.783 |
| ACE-ı/ARB therapy (%) | 72 | 70 | 0.867 |
| Aspirin therapy (%) | 96 | 93 | 0.567 |
| Diuretics therapy (%) | 23 | 21 | 0.738 |
ACE-ı/ARB=angiotensin-converting enzyme inhibitor/angiotensin receptor blocker; COPD=chronic obstructive pulmonary disease